COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,695 Articles (22,913 medRxiv, 8,782 bioRxiv)

Most recent first Previous |  Page 2387: Articles 23861-23870  | Next

Seeding of outbreaks of COVID-19 by contaminated fresh and frozen food
Fisher, D., Reilly, A., Kang Eng Zheng, A., Cook, A. R., Anderson, D.
10.1101/2020.08.17.255166 — Posted: 2020-08-18 Discussion: Onsite
SARS-CoV-2 Infection and Transmission Depends on Heparan Sulfates and Is Blocked by Low Molecular Weight Heparins
Bermejo-Jambrina, M., Eder, J., Kaptein, T. M., Helgers, L. C., Brouwer, P. J., van Hamme, J. L., Vlaar, A. P., van Baarle, F. E. H. P., de Bree, G. J., Nijmeijer, B. M., Kootstra, N. A., van Gils, M. J., Sanders, R. W., Geijtenbeek, T. B. H.
10.1101/2020.08.18.255810 — Posted: 2020-08-18 Discussion: Onsite
Spike protein mutational landscape in India: Could Mullers ratchet be a future game-changer for COVID-19?
Banerjee, R., Basak, K., Ghosh, A., Rajachandran, V., Sureka, K., Ganguly, D., Chattopadhyay, S.
10.1101/2020.08.18.255570 — Posted: 2020-08-18
Generalized linear models provide a measure of virulence for specific mutations in SARS-CoV-2 strains
Oulas, A., Zanti, M., Tomazou, M., Zachariou, M., Minadakis, G., Bourdakou, M. M., Pavlidis, P., Spyrou, G. M.
10.1101/2020.08.17.253484 — Posted: 2020-08-18
The effect of whey protein on viral infection and replication of SARS-CoV-2 and pangolin coronavirus in vitro
Fan, H., Luo, Y., Hong, B., Wang, L., Jin, X., Chen, Y., Hu, Y., Li, T., Zhuang, H., Zhou, Y.-H., Tong, Y.-G., Xiang, K.
10.1101/2020.08.17.254979 — Posted: 2020-08-18
IFITM proteins promote SARS-CoV-2 infection in human lung cells
Prelli Bozzo, C., Nchioua, R., Volcic, M., Wettstein, L., Weil, T., Krueger, J., Heller, S., Conzelmann, C., Mueller, J. A., Gross, R., Zech, F., Schuetz, D., Koepke, L., Stuerzel, C. M., Schueler, C., Stenzel, S., Braun, E., Weiss, J., Sauter, D., Muench, J., Stenger, S., Sato, K., Kleger, A., Goffinet, C., Sparrer, K. M. J., Kirchhoff, F.
10.1101/2020.08.18.255935 — Posted: 2020-08-18
In-depth blood proteome profiling analysis revealed distinct functional characteristics of plasma proteins between severe and non-severe COVID-19 patients
Park, J., Kim, H., Kim, S. Y., Kim, Y., Lee, J.-S., Seong, M.-W., Han, D.
10.1101/2020.08.18.255315 — Posted: 2020-08-18
A Lymph Node Targeted Amphiphile Vaccine Induces Potent Cellular and Humoral Immunity to SARS-CoV-2
Steinbuck, M. P., Seenappa, L. M., Jakubowski, A., McNeil, L. K., Haqq, C. M., DeMuth, P. C.
10.1101/2020.08.17.251728 — Posted: 2020-08-18
Erythroid precursors and progenitors suppress adaptive immunity and get invaded by SARS-CoV-2
Shahbaz, S., Xu, L., Osman, M., Sligl, W., Shields, J., Joyce, M., Tyrrell, L., Oyegbami, O., Elahi, S.
10.1101/2020.08.18.255927 — Posted: 2020-08-18
Heart disease mortality during the early pandemic period in the United States.
Faust, J. S., Lin, Z., Wright, K. N., Di Iorio, M. A., Walsh, C. D., Krumholz, H.
10.1101/2020.08.16.20175406 — Posted: 2020-08-18 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).